ARTL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ARTL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.
Artelo Biosciences's minority interest for the quarter that ended in Sep. 2024 was $0.00 Mil.
The historical data trend for Artelo Biosciences's Minority Interest can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artelo Biosciences Annual Data | |||||||||||||||||||||
Trend | Aug14 | Aug15 | Aug16 | Aug17 | Aug18 | Aug19 | Aug20 | Aug21 | Dec22 | Dec23 | |||||||||||
Minority Interest | Get a 7-Day Free Trial | - | - | - | - | - |
Artelo Biosciences Quarterly Data | ||||||||||||||||||||
Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Minority Interest | Get a 7-Day Free Trial | - | - | - | - | - |
Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.
Gregory D. Gorgas | director, officer: See Remarks | 888 PROSPECT, SUITE 210, LA JOLLA CA 92037 |
Tamara A Seymour | director | C/O SIGNAL GENETICS, INC., 5740 FLEET STREET, CARLSBAD CA 92008 |
Gregory Reyes | director | 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS NJ 07922 |
Matsui Connie | director | 3030 CALLAN RD, SAN DIEGO CA 92121 |
John W Beck | director | C/O RITTER PHARMACEUTICALS, INC., 1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES CA 90067 |
Robert Martin Emanuele | director | |
David J Moss | 10 percent owner | C/O PEGASI ENERGY RESOURCES CORPORATION, 218 N. BROADWAY, SUITE 204, TYLER TX 75702 |
Georgia Erbez | director | 6300 DUMBARTON CIRCLE, FREMONT CA 94555 |
Steven Kelly | director | C/O INNOVIVE PHARMACEUTICALS, INC., 555 MADISON AVENUE, 25TH FLOOR, NEW YORK NY 10022 |
Douglas Blayney | director | C/O ARTELO BIOSCIENCES, INC., 888 PROSPECT ST, SUITE 210, LA JOLLA CA 92037 |
Peter Michael O'brien | 10 percent owner | C/O ARTELO BIOSCIENCES, INC., 888 PROSPECT ST, SUITE 210, LA JOLLA CA 92037 |
From GuruFocus
By Marketwired • 11-05-2024
By Marketwired • 08-13-2024
By GuruFocus News • 10-16-2024
By GuruFocus Research • 02-06-2024
By GuruFocus News • 11-20-2024
By Marketwired • 05-29-2024
By Marketwired • 11-12-2024
By Marketwired • 10-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.